Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesFDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/21/09
The FDA has expanded its approval of Merck & Co. Inc.'s quadrivalent human papillomavirus, or HPV, vaccine, which is marketed as Gardasil, to include use of the vaccine to prevent genital warts in boys and men ages 9–26 years. The agency also has given a thumbs–up to a bivalent HPV vaccine for girls and young women. During clinical trials in more than 4,000 males, Gardasil was nearly 90 percent effective in preventing genital warts caused by infection with HPV types 6 and 11. Gardasil was approved in 2006 for use in girls and young women ages 9–26 years for the prevention of cervical cancer, vulvar cancer, vaginal cancer and precancers caused by HPV types 16 and 18; genital warts caused by HPV types 6 and 11; and precancerous or dysplastic lesions caused by HPV types 6, 11, 16, and 18. Merck's vaccine soon will have competition from GlaxoSmithKline Biologicals, or GSK. The FDA approved GSK's bivalent HPV vaccine, Cervarix, on Oct. 16 for the prevention of cervical cancer and precancerous lesions caused by HPV types 16 and 18 in girls and women ages 10–25.
Related Articles
New HPV Vaccine Might Stop Vulvar Cancer in Its Tracks
MedLinePlus, 11/06/09
Relevance Score: 88%
ACIP Supports 'Permissive Use,' But Not Routine Use, of Gardasil in Males
American Family Physician, 10/29/09
Relevance Score: 82%
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 81%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 81%
U.S. OKs Merck shot to prevent male genital warts
Reuters, 10/19/09
Relevance Score: 80%
Today in Urogenital...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections
Antimicrobial Agents and Chemotherapy, 11/20/09
Serological reactivity and bacterial genotypes in Chlamydia trachomatis urogenital infections in Guadeloupe, French West Indies
Sexually Transmitted Infections, 11/18/09
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
Diagnostic Microbiology and Infectious Disease, 11/17/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Towards the Rational Design of a Malaria Vaccine Construct; Example of the MSP3 Family, Part II: Antigenicity Studies
Infection and Immunity, 11/20/09
A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months
The Pediatric Infectious Disease Journal, 11/20/09
Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09
Article Search
Sponsor